Orange Book product · Generic (ANDA)
CARBINOXAMINE MALEATE
CARBINOXAMINE MALEATE
At a glance
Dec 19, 2024
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2024
1 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
CARBINOXAMINE MALEATE
Strength
6MG
Dosage form
TABLET
Route
ORAL
TE code
AA
Application
ANDA 215476
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARBINOXAMINE MALEATE
- 2013KARBINAL ERBrand (NDA)
NDA 022556 · AYTU
- —CLISTINBrand (NDA)
NDA 008955 · MCNEIL
- —CLISTINBrand (NDA)
NDA 008915 · ORTHO MCNEIL PHARM
- 2016CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 207484 · MIKART
- 2011CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090756 · MISSION PHARMACAL
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090417 · CYPRESS PHARM
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090418 · CYPRESS PHARM
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090435 · SENORES PHARMS
- 2008CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040639 · STRIDES PHARMA INTL
- 2008CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040814 · PH HEALTH
- 2003CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040458 · GENUS
- 2003CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040442 · GENUS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
